You searched for "regulation"
The willingness of patients to participate in an eye donation registry for research
This paper explores the willingness of ophthalmic patients to donate their eyes post-mortem for research purposes. A total of 300 German patients with a median age of 70 years (range 19-95) completed the standardised questionnaire; 45.3% were female and the...
Suspected vitreous seeding of uveal melanoma
This is a retrospective non-randomised study of 23 patients with consecutive uveal melanoma who underwent diagnostic vitrectomy between the period of January 2000 and November 2013. The reason for vitrectomy was suspected dissemination of tumour cells inside the eye. The...
IAC vs. IVC chemotherapy for RB
This a single centre retrospective review of consecutive patients between 1997 and 2014, of all sporadic unilateral retinoblastoma (RB) group D cases, treated with combined intravenous chemotherapy (IVC) and focal treatments (1997- 2008), or intra-arterial chemotherapy (IAC) treatment (2008 to...Greater awareness of children’s vision care is urged by the profession
Greater attention needs to be given to children’s vision, believes the profession, as a recent survey by Mumsnet reveals that visits to the optometrist are lower down the agenda than dental visits. It found that 9% of parents saw no...Quantum technology first in eye disease detection
Scientists are working on a new device that could lead to a reduction in the number of people who go blind from age-related macular degeneration (AMD).Study reveals increase in Charles Bonnet Syndrome symptoms due to COVID-19
A study published today in BMJ Open Ophthalmology has shown the impact of COVID-19 on those already experiencing vivid hallucinations as a result of Charles Bonnet syndrome (CBS).WATCH: Novel imaging technology reveals role of immune cells in early diabetic cataract development
In this video interview, Proffessor Ali Hafezi-Moghadam and Professor Dr. Christoph Rußmann discuss their findings on the role of immune cells in early diabetic cataract development.
Intravitreal Ziv-Aflibercept: safety analysis
Ziv-Aflibercept (Zaltrap; Sanofi-Aventis U.S LLS, Bridgewater, NJ) was originally introduced as an intravenous formulation for metastatic colorectal cancer. The adoption of Ziv-Aflibercept in ophthalmic practice was similar to bevacizumab, and reports have previously examined one to two year visual outcomes...Diary from my elective: a Parisian experience
The author explains how a research institute’s dedication to multidisciplinary collaboration helped him to discover a passion for academic ophthalmology. The elective aspect to the final year of a medical degree, through its change of scenery and immersion into another...Sustainability in eyecare: Aravind Eye Hospital’s low carbon eyecare system
The field of healthcare has a substantial impact on the environment as it is responsible for 5-10% of greenhouse gas emissions and 9% of air pollutant generation [1]. Surgery is associated with the rapid consumption of single-use products and waste...
